Revolutionizing Neuroendoscopy through Innovation
NeuroNEC is building a next-generation clinical and technological hub for ultra–minimally invasive brain & spine surgery. The idea is to replace traditional heavy surgery with fast, precise, endoscopic procedures supported by digital anesthesia, accelerated rehabilitation and advanced sensing. We combine a 24h Fast-Track clinical program, R&D in surgical innovation, training and simulation, and sustainable international outreach.
Vision: Redefine minimally invasive brain & spine surgery. Mission: Deliver ultra-fast, human-centered, innovative care worldwide while advancing R&D and training.
Patients needing minimally invasive spine/brain surgery, high-performance athletes, medtech companies, clinics/hospitals, and institutions seeking innovative fast-recovery solutions.
NeuroNEC solves the long recovery times, pain, and high complication rates of traditional brain & spine surgery. Patients lose weeks of productivity, mobility and quality of life. Hospitals lack efficient minimally invasive pathways. Our solution reduces pain, accelerates recovery to 24h, cuts costs and enables safe return to work, sport and daily life.
The problem is serious because spinal and brain disorders cause long pain, disability, lost work days, high healthcare costs, and slow recovery, deeply affecting quality of life and public health.
Our solution involves innovative neuroendoscopic techniques that significantly reduce patient recovery time and hospital costs by minimizing invasive procedures. This allows for a safer, quicker return to daily activities and enhances the quality of life post-surgery.
We combine awake endoscopic surgery, digital anesthesia and accelerated rehab into a unified 24h Fast-Track workflow. A coordinated medical team guides the patient through every optimized step.
Our solution enhances patient safety, cuts recovery time, and fosters efficiency for hospitals through cost-effective innovative surgical care.
We estimate the market size for which our solution is designed in monetary terms as follows
Is our goal in the next 3 years
My key role is CEO and Founder. I am responsible for setting the clinical strategy, developing innovative endoscopic techniques, coordinating our Xperience Program, leading R&D efforts, cultivating partnerships, and overseeing global expansion.
Our multidisciplinary team boasts expertise in various medical fields. We've collectively developed fast-track endoscopic programs with proven results.
Our competitors include traditional spine and brain surgery centers, MedTech companies (Globus, Medtronic, Brainlab), and AR/VR surgical simulation providers. None combine ultra-minimally invasive techniques, 24h Fast-Track protocols, digital anesthesia, real-world validation and a dematerialized clinical innovation hub like NeuroNEC.
NeuroNEC stands out by unifying ultra–minimally invasive brain & spine surgery with a unique 24h Fast-Track protocol, combining awake endoscopy, digital anesthesia and accelerated rehab. Our integrated clinical–R&D–simulation hub, elite multidisciplinary team and real-world tech validation make us unmatched and hard to replicate.
We generate revenue through premium surgical packages (Xperience), clinical services, consulting for MedTech companies, and partnerships with clinics and institutions.
In just half a year, we've successfully trialed our Xperience 24h Fast-Track program in clinical settings, bolstered our team with diverse talent, initiated MedTech R&D partnerships and readied for launches in Milan and Monaco. Impressively, we saw our revenue double within the first two operational months.
In the set duration, NeuroNEC will stabilize monthly surgeries at 6-8 Xperience patients, spread operations to San Marino, Milan, and Monaco, establish a global patient network, cement crucial MedTech partnerships and achieve financial breakeven with a scalable model.
Our key metrics encompass surgeries performed, Xperience patient treatments, monthly earnings, satisfaction scores and recovery timeframes. With impressive results like doubled revenue in the second month alone and sustained growth in patient volume with unwaveringly high levels of satisfaction/results - we are unstoppable.
In just two months of activity, NeuroNEC generated €30,000 in the first month and reached €60,000 at the beginning of month two. Revenue is growing fast thanks to strong patient traction and the scalability of the Xperience Program. Early financial performance shows high demand and rapid adoption of our clinical model.
Our company incorporated in
San Marino
The primary risks include regulatory approval hurdles, healthcare systems' resistance to adapt new technology, competition from established medtech companies and uncertainty about the acceptance level amongst patients and physicians.
$
100000
We raised investments
NeuroNEC is fully founder-owned. No external investors yet; 100% of the equity is held by the founder.
$
500.000
Currently, we are raising investments
$
2.000.000 €
Estimated pre-investment valuation of the company
NEC delivers ultra-minimally invasive brain & spine surgery with the Xperience Fast-Track protocol. We combine awake endoscopy, 24h rehabilitation, MedTech innovation and data-driven care to create a high-performance, patient-centered surgical ecosystem unique in Europe.